BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy

Naif H. Ali, Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Athanasios Alexiou, Marios Papadakis, Ali Abdullah AlAseeri, Mubarak Alruwaili, Hebatallah M. Saad, Gaber El Saber Batiha

Research output: Contribution to journalReview articlepeer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy'. Together they form a unique fingerprint.

Medicine and Dentistry

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science